Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Lipasin (also known as C19ORF80, RIFL, ANGPTL8 and betatrophin) is a newly discovered circulating factor that regulates lipid metabolism and promotes pancreatic β-cell proliferation. Whether circulating levels of lipasin in humans are altered in a) type 2 diabetes; b) obesity and c) the postprandial state, however, is unknown. The current study aimed to compare serum lipasin levels in those who were a) non-diabetic (N=15) or diabetic (BMI- and age-matched; N=14); b) lean or obese (N=53 totally) and c) fasting and 2 hours following a defined meal (N=12). Serum lipasin levels were determined by the enzyme-linked immunosorbent assay. Lipasin levels [mean±SEM] were increased by more than two fold (P<0.001) in the diabetic patients (5.56±0.73 ng/mL) as compared to the control subjects (2.19±0.24 ng/mL). Serum lipasin levels were positively correlated with BMI (rho=0.49, P<0.001), and showed a 35% increase 2 hours following a defined meal (P=0.009). Therefore, lipasin/betatrophin is nutritionally-regulated hepatokine that is increased in human type 2 diabetes and obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This is substantiated by the fact that betatrophin levels are higher in T2DM patients,182, 183, 184 although they were lower in one study.185”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [184]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Betatrophin: A Hormone that Controls Pancreatic β Cell Proliferation
Yi, P., Park, J.-S., & Melton, D. A. (2013) · Cell · doi:10.1016/j.cell.2013.04.008 · Cited by 449
RetractedEckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
Biological, clinical and population relevance of 95 loci for blood lipids
Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., et al. (2010) · Nature · doi:10.1038/nature09270 · Cited by 3,487
Obesity and Diabetes in the Developing World — A Growing Challenge
Hossain, P., Kawar, B., & El Nahas, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068177 · Cited by 2,200
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
Grundy, S. M. (2011) · Atlas of Atherosclerosis and Metabolic Syndrome · doi:10.1007/978-1-4419-5839-6_1 · Cited by 1,223
Selective versus Total Insulin Resistance: A Pathogenic Paradox
Brown, M. S., & Goldstein, J. L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.12.009 · Cited by 965
Uyeda, K., & Repa, J. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.06.008 · Cited by 529
Biddinger, S. B., Hernandez-Ono, A., Rask-Madsen, C., Haas, J. T., Alemán, J. O., Suzuki, R., Scapa, E. F., Agarwal, C., Carey, M. C., Stephanopoulos, G., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.013 · Cited by 469
Cited by
Items 101–200 of 230
Liu, J., Yagi, K., Nohara, A., Chujo, D., Ohbatake, A., Fujimoto, A., Miyamoto, Y., Kobayashi, J., & Yamagishi, M. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.12.011 · Cited by 20
Zou, H., Wu, D., Zhang, Z., Chen, X., Lu, P., & Yu, X. (2020) · Scientific Reports · doi:10.1038/s41598-020-69091-y · Cited by 19
Abu‐Farha, M., Melhem, M., Abubaker, J. A., Behbehani, K., Alsmadi, O. A., & Elkum, N. B. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0195-6 · Cited by 19
Moderate-Intensity Exercise and Musical Co-Treatment Decreased the Circulating Level of Betatrophin
Susanto, H., Taufiq, A., Sugiharto, Merawati, D., Badu, K. M., Purnomo, J. D. T., & Handaya, A. Y. (2020) · International Journal of Endocrinology · doi:10.1155/2020/3098261 · Cited by 18
Susanto, H., Sugiharto, S., Taufiq, A., Pranoto, A., & Purnomo, J. D. T. (2022) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2022.103546 · Cited by 19
Betatrophin in Diabetes Mellitus: the Epidemiological Evidence in Humans
Espes, D., Martinell, M., Liljebäck, H., & Carlsson, P. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0676-4 · Cited by 19
Guo, K., Yu, H., Lu, J., Bao, Y., Chen, H., & Jia, W. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.01.024 · Cited by 19
“Although the role of betatrophin in β-cell function is still controversial, most clinical studies have found that the betatrophin level was increased significantly in T2D subjects [14-19].”
BackgroundResultPlasma betatrophin levels in patients with liver cirrhosis
Arias, M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i37.10662 · Cited by 19
Erol, O. Ö., Özel, M. K., Ellidağ, H. Y., Toptaş, T., Uysal, A., & Yılmaz, N. (2017) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2017.1286464 · Cited by 18
“…HOMA-IR and gamma-glutamyl transferase levels (Guo et al. 2015), and also total and LDL cholesterol (Fenzl et al. 2014) in patients with type 2DM. Fu et al. (2014a) found that the serum betatrophin levels in type 2DM and overweight/ obese patients were significantly higher than those in…”
BackgroundMethodResultInfluentialMohany, K. M., Rugaie, O. A., Al‐Wutayd, O., Al‐Nafeesah, A., & Saleem, T. H. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00628-y · Cited by 19
Pu, D., Li, L., Jingxia, Y., Liu, R., Yang, G., Liao, Y., & Wu, Q. (2019) · Mediators of Inflammation · doi:10.1155/2019/6321427 · Cited by 17
“Although circulating ANGPTL8 levels have been reported to be related to IR [26], T2DM [27–30], obesity [27, 30], PCOS [31–33], nonalcoholic fatty liver disease (NAFLD) [34], and MetS [12, 35], ANGPTL8 is mainly secreted and expressed by hepatocytes.”
BackgroundNavaeian, M., Asadian, S., Ahmadpour Yazdi, H., & Gheibi, N. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06270-8 · Cited by 14
“[62] (2014) Increased angptl8 in obese people Serum 15cont 53 diabetic”
BackgroundIncreased Cord Blood Betatrophin Levels in the Offspring of Mothers with Gestational Diabetes
Xie, X., Gao, H., Wu, S., Zhao, Y., Du, C., Yuan, G., Ning, Q., McCormick, K. L., & Luo, X. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155646 · Cited by 18
“Some reports found that betatrophin was increased [17], whereas in other studies it was reduced [40] or unaltered [32].”
BackgroundResultInfluentialHuang, Y., Fang, C., Ma, Z., Guo, H., Wang, R., & Hu, J. (2016) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0036-1584566 · Cited by 16
Weight Loss Partially Restores Glucose-Driven Betatrophin Response in Humans
Maurer, L., Brachs, S., Decker, A.-M., Brachs, M., Leupelt, V., von Schwartzenberg, R. J., Ernert, A., Bobbert, T., Krude, H., Spranger, J., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1788 · Cited by 16
Wang, S., Hong, X., Tu, Z., & Yuan, G. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.08.025 · Cited by 16
“[33] Fu Z, Berhane F, Fite A, Seyoum B, Abou-Samra AB, Zhang R.”
Associations Between Plasma Betatrophin Levels and Coronary and Peripheral Artery Disease
Niki, H., Kishimoto, Y., Ibe, S., Saita, E., Sasaki, K., Miura, K., Ikegami, Y., Ohmori, R., Kondo, K. N., & Momiyama, Y. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.46508 · Cited by 17
Issa, Y. A., ElHafeez, S. A., & Amin, N. G. (2019) · The EPMA Journal · doi:10.1007/s13167-019-00180-3 · Cited by 16
Alenad, A. M. H., Alenezi, M. M., Alokail, M. S., Wani, K., Mohammed, A. K., Alnaami, A. M., Sulimani, M. M., Zargar, S., Clerici, M., & Al‐Daghri, N. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-63850-7 · Cited by 18
Li, L., Zhang, F., Cui, J., Shi, Y., Xiang, J., Wang, X., Zhao, N., Yan, Q.-W., Greenberg, A. S., Peng, Y., et al. (2016) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1252743 · Cited by 20
“measurement of circulating betatrophin in PCOS may lead to the confusion, muddle and controversy [11,20,21].”
Lu, Q., Li, L., Chen, W., & Lu, P. (2017) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-017-3676-z · Cited by 16
Enteshary, M., Esfarjani, F., & Reisi, J. (2019) · Asian Journal of Sports Medicine · doi:10.5812/asjsm.68943 · Cited by 17
Al‐Daghri, N. M., Rahman, S., Sabico, S., Amer, O. E., Wani, K., Ansari, M. G. A., Al-Attas, O. S., Kumar, S., & Alokail, M. S. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.05.023 · Cited by 15
Yang, L., Song, J., Zhang, X., Xiao, L., Hu, X., Pan, H., Qin, L., Liu, H., Ge, B., & Zheng, T. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00414 · Cited by 16
Investigation of Blood Betatrophin Levels in Obese Children with Non-Alcoholic Fatty Liver Disease
Battal, F., Türkön, H., Aylanç, N., Aylanç, H., Yıldırım, Ş., Kaymaz, N., & Uysal, S. (2018) · Pediatric Gastroenterology Hepatology & Nutrition · doi:10.5223/pghn.2018.21.2.111 · Cited by 15
Brain-acting hepatokines: its impact on energy balance and metabolism
Giovanini, L., Wanionok, N. E., Perelló, M., & Cornejo, M. P. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1589110 · Cited by 16
“Plasma ANGPTL8 levels are also increased in individuals with T1DM (Espes et al., 2014), T2DM (Espes et al., 2014; Fu et al., 2014; Hu et al., 2014) and obesity (Fu et al., 2014), and positively correlate with hepatic steatosis in MASLD patients (von Loeffelholz et al., 2017).”
Vahdat‐Lasemi, F., Farhoudi, L., Hosseinikhah, S. M., Santos, R. D., & Sahebkar, A. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119235 · Cited by 14
Adamska, A., Łebkowska, A., Jacewicz‐Święcka, M., Krentowska, A., Hryniewicka, J., Wołczyński, S., Górska, M., & Kowalska, I. (2017) · International Journal of Endocrinology · doi:10.1155/2017/2316986 · Cited by 14
“The authors evaluated 12 nonobese nondiabetic subjects and observed a statistically significant increase in serum betatrophin concentrations 2 hours after a mixed meal containing carbohydrate, protein, and fat [29].”
BackgroundBetatrophin association with serum triglyceride levels in obstructive sleep apnea patients
Sertoğullarından, B., Kömüroğlu, A. U., Üçler, R., Günbatar, H., Sunnetcioglu, A., & Çokluk, E. (2019) · Annals of Thoracic Medicine · doi:10.4103/atm.atm_52_18 · Cited by 15
Hao, Q., Zheng, A., Zhang, H., & Cao, H. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01493-1 · Cited by 14
Roth, C. L., Elfers, C., Lass, N., & Reinehr, T. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12412 · Cited by 14
“2017;18:485–491. wileyonlinelibrary.com/journal/pedi 485 circulating betatrophin levels8 while other studies found increased levels compared to lean subjects and T2D.7,9 In addition, reduced betatrophin levels have been shown in adult subjects with impaired glucose tolerance (IGT) and T2D.8 Wang et al. demonstrated hi…”
ResultZheng, J., Liu, J., Hong, B. S., Ke, W., Huang, M., & Li, Y. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-0531-8 · Cited by 18
“However, as are inconsistent with the results of animal experiments, many clinical studies [10, 12, 13, 36, 37] including the present study did not find any relationship between betatrophin and triglycerides.”
BackgroundResultIncreased Levels of Circulating IGFBP4 and ANGPTL8 with a Prospective Role in Diabetic Nephropathy
Al-Majed, H. T., Abu‐Farha, M., ALSHAWAF, E. M. M., Devarajan, S., Alsairafi, Z. K., EL-Helaly, A. E., Cherian, P., Al‐Khairi, I., Ali, H., Jose, R. M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814244 · Cited by 13
Increased serum levels of betatrophin in pancreatic cancer-associated diabetes
Susanto, H., Liu, T.-Y., Chen, C.-C., Purnomo, J. D. T., Chen, S.-F., & Wang, C.-H. (2016) · Oncotarget · doi:10.18632/oncotarget.9815 · Cited by 15
“com/oncotarget A number of studies have showed that betatrophin levels were correlated with T1D and T2D and increased in T1D and T2D patients [11, 12, 23, 30].”
BackgroundTranscriptional Regulation of the Angptl8 Gene by Hepatocyte Nuclear Factor-1 in the Murine Liver
Watanabe, T., Ozawa, A., Masuda, S., Yoshino, S., Ishida, E., Kondo, Y., Matsumoto, S., Katano-Toki, A., Horiguchi, K., Nakajima, Y., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-66570-0 · Cited by 13
Luo, D., Chen, X., Yang, W., Ran, W., & Wen, Z. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0725-7897 · Cited by 14
Liu, D., Qu, H., Wang, H., Duan, Y., Liu, F., Feng, Z., & Deng, H. (2016) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2016.08.004 · Cited by 13
Xu, J., Lin, Y., Zhou, H. R., Zhao, L., & Xiang, G. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-108911 · Cited by 13
“Several recent clinical studies have also found the significantly positive correlation was observed between betatrophin and DM [34, 35].”
BackgroundAkdemir, E., Şahin, E., Madendağ, Y., Şahin, M. E., Madendağ, İ. Ç., Açmaz, G., Özdemir, F., Muhtaroğlu, S., & Müderris, İ. İ. (2020) · Placenta · doi:10.1016/j.placenta.2020.07.018 · Cited by 13
Betatrophin expression is promoted in obese hyperinsulinemic type 2 but not type 1 diabetic mice
Li, E., Nakata, M., Shinozaki, A., Yang, Y. K., Zhang, B., & Yada, T. (2016) · Endocrine Journal · doi:10.1507/endocrj.ej16-0164 · Cited by 12
“The serum level of betatrophin protein is increased within 2h after meal in healthy human individuals [21].”
BackgroundALSHAWAF, E. M. M., Al‐Ozairi, E., Al-Asfar, F., Albeloushi, S., Kumari, S., Tuomilehto, J., & Arefanian, H. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.05.026 · Cited by 12
Lee, S., Rhee, M., Kwon, H., Park, Y., & Yoon, K. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.42.1.53 · Cited by 12
“However, contradictory results were also reported with either no difference or lower levels of betatrophin in subjects with T2DM, obesity, and dyslipidemia when compared to control groups [12,14,19,26].”
BackgroundResultInfluentialHassan, A. B., Salih, S. F., Hassan, I. I., Saadi, F. S., Abdulah, D. M., Ahmed, I. H., Taher, S. M., & Khaleel, B. B. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.11.016 · Cited by 12
Hammad, M. M., Channanath, A. M., Abu‐Farha, M., Rahman, A., Khairi, I. A., Cherian, P., Alramah, T., Alam-Eldin, N., Al‐Mulla, F., Thanaraj, T. A., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1314211 · Cited by 11
Increased circulating full-length betatrophin levels in drug-naïve metabolic syndrome
Liu, D., Li, S., He, H., Yu, C., Li, X., Liang, L., Chen, Y., Li, J., Li, J., Sun, X., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15102 · Cited by 11
Abu‐Farha, M., Madhu, D., Hebbar, P., Mohammad, A., Channanath, A. M., Kavalakatt, S., Alam-Eldin, N., Alterki, F., Taher, I., Alsmadi, O. A., et al. (2023) · Cells · doi:10.3390/cells12212563 · Cited by 11
“ANGPTL8 plays an important role in lipid and glucose metabolism and is widely associated with various metabolic disorders, such as obesity and T2D, with more recent studies highlighting its role in inflammation [13,36].”
BackgroundBiological Pathways Leading From ANGPTL8 to Diabetes Mellitus–A Co-expression Network Based Analysis
Siddiqa, A., Cirillo, E., Tareen, S. H. K., Ali, A., Kutmon, M., Eijssen, L., Ahmad, J., Evelo, C. T., & Coort, S. L. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01841 · Cited by 11
Bulmuş, F. G., Melekoğlu, R., Gürsu, M. F., Bağcı, H., Kavak, E. Ç., & Akyol, A. (2020) · Journal of Turkish Society of Obstetric and Gynecology · doi:10.4274/tjod.galenos.2020.67026 · Cited by 10
“Studies have demonstrated that the expression of betatrophin is induced by insulin, food intake, and cold exposure, but is suppressed by starvation(8,9).”
BackgroundANGPTL8 Gene Polymorphism rs2278426 Is Related to Carotid Intima–Media Thickness in T2DM
Guo, C. Y., Zhao, L., Ding, Y., Zhao, Z., Wang, C., Li, L., Cai, Z., Li, Y., Xia, H., Zhu, Z.-Z., et al. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s274759 · Cited by 11
Inoue, Y., Ienaga, M., Kamiya, T., Adachi, T., Ohta, M., & Hara, H. (2022) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbac043 · Cited by 10
New insights into the inter-organ crosstalk mediated by ChREBP
Carbinatti, T., Régnier, M., Parlati, L., Benhamed, F., & Postic, C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1095440 · Cited by 14
“Stimulated by feeding, ANGPTL8 has been recognized as a direct ChREBP target due to the identification of a ChoRE on the Angptl8 promoter ranging from -398 bp to -382 bp from the transcriptional binding site (49).”
BackgroundSerum betatrophin levels are reduced in patients with full-blown polycystic ovary syndrome
Haydardedeoğlu, F. E., Bağır, G. Ş., Haydardedeoğlu, B., Bozkırlı, E., Bakıner, O., Metin, K., & Ertörer, M. E. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1519791 · Cited by 10
“Some of the kits use antibodies that recognize the N-terminus, while others recognize the C-terminus [9].”
BackgroundEl-Lebedy, D. H. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.107421 · Cited by 10
Tavassoli, H., & Heidarianpour, A. (2021) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2021.05.023 · Cited by 10
Sadeghipour, H. R., Yeganeh, G., Zar, A., Salesi, M., Akbarzadeh, S., & Bernardi, M. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1849310 · Cited by 8
“2018) and following 12weeks of Nordic walking in overweight/obese humans “with impaired glucose regulation” (Korkmaz et al. 2019). Pang et al. (2018) observed that an improvement of plasma irisin in mice occurs right after the aerobic exercise (Pang et al.”
BackgroundSönmez, A., Doğru, T., Erçin, C. N., Genç, H., Çelebi, G., Gürel, H., Tapan, S., Çiçek, A. F., Barçın, C., Haymana, C., et al. (2021) · Metabolites · doi:10.3390/metabo11070425 · Cited by 9
“Likewise, the reports about the betatrophin levels in the obese subjects are controversial [9,12,13].”
BackgroundGuo, Q., Cao, S., & Wang, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810630 · Cited by 10
“In addition, PGC-1α and betatrophin are associated with energy consumption or heat generation [5,23].”
BackgroundZhang, D., Yu, Y., Xu, F., Yuan, J., Wang, R., Zhang, C., Wang, L., Liu, Y., Song, L., Liu, J., et al. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10719 · Cited by 10
Zielińska, A., Maciulewski, R., Siewko, K., Popławska‐Kita, A., Lipińska, D., Kozłowska, G., Górska, M., & Szelachowska, M. (2016) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.07.029 · Cited by 9
Cloning, Expression, Purification and CD Analysis of Recombinant Human Betatrophin.
Gholami, S., Gheibi, N., Falak, R., & Chegini, K. G. (2018) · Europe PMC (PubMed Central) · Cited by 8
Relationship Between Angiopoietin-Like Protein 8 and Fasting Serum Triglyceride Level
Yamada, H., Kusaka, I., Saikawa, R., Hara, K., Kakei, M., & Ishikawa, S. (2017) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3286w · Cited by 8
“A previous study demonstrated elevated postprandial (2 h after a meal) ANGPTL8 levels [16].”
BackgroundANGPTL8 in cardio-metabolic diseases
Su, X., Cheng, Y., & Wang, B. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.05.017 · Cited by 8
Fu, C., Oczypok, E. A., Ali, H., DeLany, J. P., Reeves, V. L., Chang, R., & Kershaw, E. E. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.04.006 · Cited by 8
Plasma Betatrophin Levels and Carotid Atherosclerosis
Niki, H., Kishimoto, Y., Saita, E., Ohmori, R., Kondo, K. N., & Momiyama, Y. (2019) · Disease Markers · doi:10.1155/2019/4214650 · Cited by 9
Potential of Phage Display Antibody Technology for Cardiovascular Disease Immunotherapy
Yeoh, S. G., Sum, J.-S., Lai, J. Y., Isa, W. Y. H. W., & Lim, T. S. (2021) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-021-10169-x · Cited by 8
Keikha, F., Tehraninejad, E. S., Rakhshkhorshid, M., Afiat, M., Haghollahi, F., & Ghasemi, F. (2022) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.18502/ijrm.v20i1.10406 · Cited by 8
“Also, some contradictory results regarding the association of betatrophin levels and obesity have been reported (17, 18).”
BackgroundResultNakano, M., Suzuki, Y., Haga, S., Yamauchi, E., Kim, D., Nishihara, K., Nakajima, K., Gotoh, T., Park, S., Baik, M., et al. (2018) · Journal of Animal Science · doi:10.1093/jas/sky162 · Cited by 7
Cahová, M., Habart, D., Olejár, T., Berková, Z., Papáčková, Z., Daňková, H., Lodererová, A., Heczková, M., & Saudek, F. (2017) · Physiological Research · doi:10.33549/physiolres.933339 · Cited by 6
Özyazgan, S., Önal, B., Kurtuluş, E. M., Uzun, H., Akkan, G., & Konukoğlu, D. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-104383 · Cited by 6
“[10] were similar to our results that the levels of plasma lipid parameters were not different between groups, and was no correlation between plasma betatrophin and plasma lipids in T2DM was established.”
ResultThe role of ANGPTL8 in metabolism and cardiovascular diseases: Consensus and controversy
Lin, Y., Wang, D., Li, D., Zhang, F., Zhu, Q., Bao, X., Zhang, N., Alsalman, Z. M., Chen, S., Jiao, X., et al. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.120556 · Cited by 5
Zheng, L., Fang, C., Yan, J., Li, H., & Tu, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-11750-8 · Cited by 5
Bayat, M., Alaee, M., Akbari, A., Sadegh, M., Latifi, S. A., Parastesh, M., Salehi, M., Karami, H., & Amri, J. (2020) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2019-0046 · Cited by 6
Xu, F., Shen, L., Yang, Y., Kong, L., Zu, W., Tian, D., Xuanchao, C., & Huang, G. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s411483 · Cited by 5
Dyslipidemia and ANGPTL8 evaluation in young females with Type 1 diabetes mellitus
Mohammedsaeed, W. M., & Binjawhar, D. N. (2024) · Endocrine · doi:10.1007/s12020-024-03909-x · Cited by 5
Unraveling the mechanisms of hepatogenous diabetes and its therapeutic perspectives
Yadav, M. C., Verma, S., Tiwari, P., & Mugale, M. N. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122934 · Cited by 5
Garrett, J. M., McCormick, J. J., King, K. E., Meade, R. D., Boulay, P., Sigal, R. J., O’Connor, F. K., & Kenny, G. P. (2025) · Physiological Reports · doi:10.14814/phy2.70411 · Cited by 5
ALSHAWAF, E. M. M., Abu‐Farha, M., Mohammad, A., Devarajan, S., Al‐Khairi, I., Cherian, P., Ali, H., Al-Matrouk, H., Al‐Mulla, F., Alattar, A., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12050949 · Cited by 6
Abdelhameed, F., Lagojda, L., Kite, C., Dallaway, A., Mustafa, A., Than, N. N., Kassi, E. N., Randeva, H. S., & Kyrou, I. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1574842 · Cited by 5
Rashvand, F., Irandoust, K., Taheri, M., Khoei, S. G., & Gheibi, N. (2022) · Asian Journal of Sports Medicine · doi:10.5812/asjsm-120515 · Cited by 4
“In research by Tang et al., the antidiabetic effects of propolis led to a significant decrease in insulin resistance in T2D rats with high-fat diet-fed (21); similar re-sults were also reported by Kitamura et al. and Fukuda et al. (25, 29).”
BackgroundInfluentialCloning, expression, and spectral analysis of mouse betatrophin
Gholami, S., Chegini, K. G., Gheibi, N., Mokhtarian, K., Mohamadi, M., & Falak, R. (2017) · Medical Journal of the Islamic Republic of Iran · doi:10.14196/mjiri.31.102 · Cited by 4
“One study revealed that betatrophin is elevated in type 2 diabetics (3), whereas in another study no difference in betatrophin levels was found between healthy controls and patients with type 2 diabetes (11).”
BackgroundInsulin resistance and adaptation of pancreatic beta cells during pregnancy
Zielińska-Maciulewska, A., Kretowski, A. J., & Szelachowska, M. (2018) · Clinical Diabetology · doi:10.5603/dk.2018.0022 · Cited by 4
Keyif, B., Çelik, H. G., Balcı, B. K., Celebi, M., Özaltın, S., Takmaz, Ö., Buyru, F., & Baştu, E. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2020.1725964 · Cited by 4
“reported that serum betatrophin levels were positively correlated with BMI and showed a 35% increase 2 h following a defined meal [11].”
BackgroundANGPTL3/8: one target, multiple lipid disorders
Zhang, R. (2025) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2025.10.003 · Cited by 3
Self-citationDemircan, S., Önalan, E., Kuloğlu, T., Aydın, S., Yalçın, M. H., Gözel, N., & Dönder, E. (2020) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v91i4.8944 · Cited by 3
“Several studies have shown increased levels of serum betatrophin in obesity and diabetes (31-33).”
BackgroundPérez-López, F. R., Yuan, J., Prieto, M. S., López-Baena, M. T., Pérez‐Roncero, G. R., & Varikasuvu, S. R. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3612 · Cited by 5
New insights into ANGPTL8 in modulating the development of cardio-metabolic disorder diseases
Su, X., Zhang, G., Cheng, Y., & Wang, B. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06335-8 · Cited by 3
ANGPTL3 and ANGPTL8 in Thai subjects with hyperalphalipoproteinemia and severe hypertriglyceridemia
Kaewkrasaesin, C., Chatchomchuan, W., Muanpetch, S., & Khovidhunkit, W. (2021) · Journal of clinical lipidology · doi:10.1016/j.jacl.2021.08.059 · Cited by 3
Horn, P., Radtke, S., Metzing, U. B., Steidl, R., Sponholz, C., Sommerfeld, O., Roth, J., Claus, R. A., Birkenfeld, A. L., Settmacher, U., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10123151 · Cited by 3
“We further included surgical patients suffering from insulin resistance and lowgrade inflammation yet free from infection or sepsis as one control group, since betatrophin/ANGPTL8 in circulation and tissue expression rates can be altered under such conditions [19,20].”
BackgroundAssociation between circulating betatrophin levels and T2DM: a meta-analysis
Yuquan, Z. H. A. N. (2024) · Minerva Endocrinology · doi:10.23736/s2724-6507.23.04073-3 · Cited by 2
Leutner, M., Matzhold, C., Bellach, L., Deischinger, C., Stefan Thurner, A., Klimek, P., & Kautzky‐Willer, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-70075-1 · Cited by 2
Timurkaan, M., & Ayyıldız, H. (2022) · Çukurova medical journal (Online)/Çukurova medical journal · doi:10.17826/cumj.1038569 · Cited by 2
The minor allele of ANGPTL8 rs2278426 has a protective effect against CAD in T2DM patients
Bilgin, A. G., Ekici, B., Ozuynuk, A. S., Erkan, A. F., & Çoban, N. (2024) · Gene · doi:10.1016/j.gene.2024.148418 · Cited by 3
Alduraywish, A. A. (2017) · Journal of Endocrinology and Metabolism · doi:10.14740/jem405w · Cited by 2
Positive correlation of ANGPTL8 expression in human visceral adipose tissue with body mass index
Chen, S.-M., Huang, T., Lee, W., Chuang, L., & Chang, T. (2024) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2023.12.018 · Cited by 3
L’internista ospedaliero nella gestione del paziente diabetico complesso
Magnani, G. E. L., Beltramello, G., Brancato, D., Fontanella, A., & Nardi, R. (2018) · Italian Journal of Medicine · doi:10.4081/itjm.q.2018.2 · Cited by 2
Salama, M. M., Kabiel, W. A. Y., Hana, S. S., & Mohamed, G. A. (2020) · Egyptian Liver Journal · doi:10.1186/s43066-020-00039-7 · Cited by 2
Alduraywish, A. A. (2021) · Journal of International Medical Research · doi:10.1177/03000605211067125 · Cited by 2
Wong, B. C., Chau, C. K., Ao, F., Mo, C., Wong, S., Wong, Y. H., & So, H. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/140590 · Cited by 4
Akar, F., Güney, C., Özer, H., Pektaş, M. B., Koca, H. B., Kocabaş, A., & Sadı, G. (2021) · Istanbul Journal of Pharmacy · doi:10.26650/istanbuljpharm.2021.933139 · Cited by 1
Targeted Metabolomics Analysis of Individuals Carrying the ANGPTL8 R59W Variant
Abu‐Farha, M., Joseph, S., Mohammad, A., Channanath, A. M., Taher, I., Al‐Mulla, F., Mujammami, M. H., Thanaraj, T. A., Abubaker, J. A., & Rahman, A. M. A. (2023) · Metabolites · doi:10.3390/metabo13090972 · Cited by 2
Metadata
- Authors
- Fu, Z., Berhane, F., Fite, A., Seyoum, B., Abou-Samra, A. B., & Zhang, R.
- Affiliations
- Wayne State University (US)
- Corresponding author
- Zhang, Ren
- Venue
- Scientific Reports
- Published
- 2014-05-23
- Volume
- 4
- Issue
- 1
- Pages
- 5013-5013
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5381405
- OpenAlex
- W2154364167
- Cited by
- 232
- References
- 22
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 13 · 2023: 13 · 2022: 16 · 2021: 17 · 2020: 25 · 2019: 18 · 2018: 22 · 2017: 31 · 2016: 32 · 2015: 24 · 2014: 7
- FWCI
- 23.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-sa
- creativecommons.org/licenses/by-nc-sa/3.0/ (tdm)
- creativecommons.org/licenses/by-nc-sa/3.0/ (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- Wayne State University (176412)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- betatrophin, type 2 diabetes, obesity, hepatokines, postprandial lipemia, body mass index, pancreatic beta-cell proliferation, lipid metabolism, serum biomarkers
- MeSH terms
- Angiopoietin-like Proteins, Angiopoietin-Like Protein 8, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Humans, Male, Middle Aged, Obesity, Prognosis, Biomarkers, Case-Control Studies, Peptide Hormones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.